Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Status:
Completed
Trial end date:
2012-02-02
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest safe dose of lomustine (CCNU,
CeeNUTM) that can be given with temozolomide (TemodarTM) and thalidomide (ThalomidTM) in the
treatment of metastatic melanoma that has spread to the brain. The safety and effectiveness
of this combination therapy will also be studied.